Monthly News Roundup - January 2022

Skyrizi Gains Second Approval to Treat Adults with Psoriatic Arthritis Psoriatic arthritis (PsA) is an inflammatory disease of the skin and joints and impacts approximately 30% of patients with psoriasis. In response, the U.S. Food and Drug...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news